IL132951A0 - Compounds preparation and use for transferring nucleic acids into cells - Google Patents

Compounds preparation and use for transferring nucleic acids into cells

Info

Publication number
IL132951A0
IL132951A0 IL13295198A IL13295198A IL132951A0 IL 132951 A0 IL132951 A0 IL 132951A0 IL 13295198 A IL13295198 A IL 13295198A IL 13295198 A IL13295198 A IL 13295198A IL 132951 A0 IL132951 A0 IL 132951A0
Authority
IL
Israel
Prior art keywords
nucleic acids
cells
transferring nucleic
compounds
compounds preparation
Prior art date
Application number
IL13295198A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL132951A0 publication Critical patent/IL132951A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13295198A 1997-05-28 1998-05-25 Compounds preparation and use for transferring nucleic acids into cells IL132951A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706549A FR2763943B1 (fr) 1997-05-28 1997-05-28 Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules
PCT/FR1998/001041 WO1998054130A1 (fr) 1997-05-28 1998-05-25 Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules

Publications (1)

Publication Number Publication Date
IL132951A0 true IL132951A0 (en) 2001-03-19

Family

ID=9507333

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13295198A IL132951A0 (en) 1997-05-28 1998-05-25 Compounds preparation and use for transferring nucleic acids into cells

Country Status (17)

Country Link
US (1) US6300321B1 (zh)
EP (1) EP0984925B1 (zh)
JP (1) JP4467084B2 (zh)
KR (1) KR20010013029A (zh)
CN (1) CN1131208C (zh)
AT (1) ATE284383T1 (zh)
AU (1) AU738320B2 (zh)
BR (1) BR9809506A (zh)
CA (1) CA2290664C (zh)
DE (1) DE69828045T2 (zh)
FR (1) FR2763943B1 (zh)
HU (1) HUP0001937A3 (zh)
IL (1) IL132951A0 (zh)
NO (1) NO314497B1 (zh)
PL (1) PL336983A1 (zh)
WO (1) WO1998054130A1 (zh)
ZA (1) ZA984440B (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960540B2 (en) 1999-04-08 2011-06-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
EP1181304B1 (en) 1999-04-08 2007-10-10 Antisoma Research Limited Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
US8114850B2 (en) 1999-04-08 2012-02-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
EP1370295A2 (en) * 2000-11-29 2003-12-17 Gencell S.A. Neutral and anionic colloidal particles for gene delivery
US20030134423A1 (en) * 2002-01-04 2003-07-17 Chu Yong Liang Compounds for delivering substances into cells
EP1513538A4 (en) * 2002-06-14 2007-08-22 Mirus Bio Corp Novel methods for introducing polynucleotides into cells
US7906122B2 (en) * 2003-06-18 2011-03-15 Yissum Research Development Company Of The Hebrew University Of Jersusalem Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
EP1638610B1 (en) * 2003-06-18 2015-03-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Sphingoid polyalkylamine conjugates for vaccination
GB0413613D0 (en) * 2004-06-17 2004-07-21 Univ London Small molecule carriers
KR100699279B1 (ko) * 2005-04-28 2007-03-23 학교법인 포항공과대학교 당 또는 당 유사체를 골격으로 하는 분자 수송체 및 그의제조방법
US7973084B2 (en) 2005-04-28 2011-07-05 Postech Academy-Industrial Foundation Molecular transporters based on alditol or inositol and processes for the preparation thereof
BRPI0614805A2 (pt) * 2005-08-10 2011-04-12 Univ Johns Hopkins poliaminas úteis como produtos terapêuticos antiparasìticos e anticáncer e como inibidores de demetilase lisina-especìficos
GB0613753D0 (en) * 2006-07-11 2006-08-23 Norwegian Radium Hospital Res Method
WO2013086354A1 (en) 2011-12-07 2013-06-13 Alnylam Pharmaceuticals, Inc. Biodegradable lipids for the delivery of active agents
PL3766916T3 (pl) 2014-06-25 2023-02-27 Acuitas Therapeutics Inc. Nowe lipidy i formulacje nanocząstek lipidowych do dostarczania kwasów nukleinowych
PT3313829T (pt) 2015-06-29 2024-07-08 Acuitas Therapeutics Inc Formulações de lípidos e de nanopartículas lipídicas para a administração de ácidos nucleicos
WO2017075531A1 (en) 2015-10-28 2017-05-04 Acuitas Therapeutics, Inc. Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
WO2018191657A1 (en) 2017-04-13 2018-10-18 Acuitas Therapeutics, Inc. Lipids for delivery of active agents
CA3061612A1 (en) 2017-04-28 2018-11-01 Acuitas Therapeutics, Inc. Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
US11639329B2 (en) 2017-08-16 2023-05-02 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
US11542225B2 (en) 2017-08-17 2023-01-03 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
WO2019036030A1 (en) 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
WO2019036000A1 (en) 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
KR20210138569A (ko) 2019-01-11 2021-11-19 아퀴타스 테라퓨틱스 인크. 활성제의 지질 나노입자 전달을 위한 지질
AU2021308681A1 (en) 2020-07-16 2023-03-09 Acuitas Therapeutics, Inc. Cationic lipids for use in lipid nanoparticles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ276975A (en) * 1993-11-24 1998-04-27 Megabios Corp Guanidine based amphiphiles and their use in liposomes for delivering genetic material intracellularly
US5777153A (en) * 1994-07-08 1998-07-07 Gilead Sciences, Inc. Cationic lipids
FR2727679B1 (fr) * 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
FR2730637B1 (fr) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
FR2741066B1 (fr) * 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
DE69703878T2 (de) * 1996-03-01 2001-04-26 Centre National De La Recherche Scientifique (C.N.R.S.), Paris Guanidinium-verbindungen, pharmazeutische präparate davon und ihre verwendungen

Also Published As

Publication number Publication date
NO995808D0 (no) 1999-11-26
NO995808L (no) 1999-11-26
US6300321B1 (en) 2001-10-09
FR2763943A1 (fr) 1998-12-04
CN1131208C (zh) 2003-12-17
EP0984925B1 (fr) 2004-12-08
WO1998054130A1 (fr) 1998-12-03
EP0984925A1 (fr) 2000-03-15
DE69828045T2 (de) 2005-12-01
ATE284383T1 (de) 2004-12-15
CA2290664A1 (fr) 1998-12-03
NO314497B1 (no) 2003-03-31
JP2002502388A (ja) 2002-01-22
DE69828045D1 (de) 2005-01-13
HUP0001937A2 (hu) 2000-10-28
CN1257480A (zh) 2000-06-21
KR20010013029A (ko) 2001-02-26
FR2763943B1 (fr) 1999-07-09
ZA984440B (en) 1998-12-10
AU8022198A (en) 1998-12-30
PL336983A1 (en) 2000-07-31
HUP0001937A3 (en) 2003-10-28
BR9809506A (pt) 2000-06-20
JP4467084B2 (ja) 2010-05-26
AU738320B2 (en) 2001-09-13
CA2290664C (fr) 2010-04-13

Similar Documents

Publication Publication Date Title
IL132951A0 (en) Compounds preparation and use for transferring nucleic acids into cells
HUP0004134A2 (en) Determination of cellular growth abnormality
FI972514A (fi) Kasvainspesifisten sytotoksisten T-solujen in vivo aktivointi
AU6842001A (en) Pluripotent mammalian cells
AU4193700A (en) Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
AU9102898A (en) Pluripotential bone marrow cell line and methods of using the same
EP1775345A3 (en) Vector constructors
IL133883A0 (en) Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents
AU2445601A (en) Mammalian protein phosphatases
GB9930519D0 (en) Uses of transport proteins
AU3161401A (en) Methods for the preparation and use of internal standards for nucleic acid amplification assays
EP1078639A4 (en) STABLE GENERATION
IL137247A0 (en) Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
EP1218393A4 (en) CELL TARGETING COMPOSITIONS AND METHODS OF USE THEREOF
AU2002218460A1 (en) Transportation of biological specimens
AU7836798A (en) Compositions for delivery of biological agents and methods for the preparation thereof
WO2002028874A3 (en) Tumor proliferation inhibitors
AU2002220262A1 (en) Sdf-1 beta expressing tumor cells as tumor vaccines
AU4774200A (en) Long term cell culture of human carcinoma
GB9818445D0 (en) Medicaments
AU3862197A (en) (in vitro) evolution of oligonucleotides
GB2332909B (en) Glycerol-based fluidifing substance
WO1999059638A8 (en) Compositions and methods for the delivery of nucleic acid molecules
AU7075398A (en) Continuous (in vitro) evolution of oligonucleotides
EP1090646A3 (en) Labelled d-mannoheptulose derivatives and their use for imaging of the endocrine pancreas